Status:
UNKNOWN
Animal-Assisted Therapy in Patients With Schizophrenia
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Schizophrenia
Animal-assisted Therapy
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
Animal-assisted therapy (AAT) can be helpful to improve the psychiatric, emotional, physical,and social status in patients with physical and mental illness and the elderly. The study aims to investig...
Detailed Description
Animal-assisted therapy (AAT) can be helpful to improve the outcomes of psychiatric and emotional symptoms, physical activeness, social skills, well-beings in patients with physical and mental illness...
Eligibility Criteria
Inclusion
- Having a diagnosis of schizophrenia according to the DSM-5.
- Adult aged 40 years or older.
- Having stable physical and psychological health conditions based on master clinician judgment.
- Having the will to participate in the study after thorough comprehension of the content.
- Not receiving treatment protocol last half a year.
Exclusion
- Severe cognitive impairment e.g. aphasia, being unable to follow 3 or more orders.
- Being allergic to animals.
- History of Asthma.
- Coagulation disorders
- presenting symptoms of specific phobia, anxiety disorder and obsessive-compulsive disorder in context of dog, infection and contamination.
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04476836
Start Date
August 1 2020
End Date
December 1 2020
Last Update
July 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital, Kaohsiung Medical Center
Kaohsiung City, Taiwan, 833